ISoP

The mission of the International Society of Pharmacometrics (ISoP) is to advance the field of Pharmacometrics globally.

[ISoP @ISOP1]

🚀 Extend your #ACoP2026 experience with Industry Partner Workshops!

Join specialized pre- and post-conference workshops on Oct 10–11 and Oct 15–16 for additional training, learning, and networking opportunities.

⚠️ Registration required, info: https://t.co/j12iaccXsH

[ISoP @ISOP1]

📢 Check out August's ISoP MIDD Series Webinar

Efficient Pediatric Dose Optimization Leveraging Adult Population Pharmacokinetics and Bayesian Forecasting

🗓️ Wed August 26, 2026 | ⏰ 12:00–1:00 PM ET
🎤 Tu Mai
🔗 Register https://t.co/LXtGhkZypy

#ISoP #MIDD #RP2D

[ISoP @ISOP1]

📢 The ISoP AI/ML Special Interest Group announces a new member of their leadership team.

Niklas Korsbo: Benchmarking Dataset Working Group Co-Lead.

ISoP Members may join the AI/ML SIG as a member benefit.

👉SIG info https://t.co/IFasy75FsB

#ISoP #MemberBenefit #AIML

[ISoP @ISOP1]

🎤 Linda Griffith (MIT) will deliver the #ACoP2026 State-of-the-Art Lecture, "Computational and Experimental NAMs: A Symbiotic Relationship in Drug Development." Learn how NAMs, QSP, and organs-on-chips are shaping the future of drug development. 🚀

🔗https://t.co/6a2N2tpKUQ

[ISoP @ISOP1]

🚨 New in Quantitative Medicine

From ANC Oscillations Towards an Improved Childhood ALL Maintenance Therapy

📖 Read the full article https://t.co/ARpOtRuQq3

#ISoP#QuantitativeMedicine #Pharmacometrics #PrecisionMedicine #PediatricOncology #ModelInformedDrugDevelopment

[ISoP @ISOP1]

⏱️ Ready to publish? Don’t wait.

With continuous publishing, your research is shared as soon as it’s ready—no waiting for issue releases.

📥 Submit your work and accelerate its impact: global visibility, open access, real reach. https://t.co/kIKM4PblsS

#QuantitativeMedicine

[ISoP @ISOP1]

📢 QSP students & trainees: Showcase your research at the ISoP QSP Virtual Student Symposium!

🗓 Sept. 8, 2026 | ⏰ 10 AM–2 PM ET | 💻 Virtual

Submit abstracts in:🔹 Applications🔹 Methodologies🔹 Disease Models
🚨 Deadline: July 31
👉 Details: https://t.co/KwFkjEZG5C

#ISoP

[ISoP @ISOP1]

🌟 Meet Another Leader Empowering ISoP’s Next Generation 🌟

We’re excited to spotlight the volunteers serving on the Students, Trainees & Early career Professionals (STEP) Committee leadership.

👉 Learn about ISoP student membership https://t.co/Oj5CQ5G3kE

#ISoP

[ISoP @ISOP1]

📣 Secure your ACoP 2026 Early Bird registration before it closes!

🚨 30+ educational sessions, 400+ posters, inaugural Hackathon, workshops, tutorials, networking and more!

🔗 Register https://t.co/AwzQtysXnP

#ACoP2026 #EarlyBirdRegistration #ISoP

[ISoP @ISOP1]

📢 New in Quantitative Medicine:
Bayesian Inference of Population PK/PD Parameters using Normalizing Flows

📖 Read the article and explore how Normalizing Flows are transforming population PK/PD analysis. https://t.co/5j6ECZWT5n

#QuantitativeMedicine #Pharmacometrics #ISoP

[ISoP @ISOP1]

ISoP’s mission is to advance quantitative approaches that improve patient outcomes worldwide.

🌍 When you give, you invest in a global scientific community working together to drive better decision‑making and better science.

👉 Support #ISoP on July 4: https://t.co/lqTOU7Z6ni

[ISoP @ISOP1]

📣 MIDD Series Webinar
Model-Based Dose Selection and Pharmacokinetic Bridging of Subcutaneous from Intravenous Pembrolizumab Across Indications

📅 July 21 | 12 PM ET
🎤 Gina Song & Mallika Lala

🔗 Register now https://t.co/Nl7gsnnwrW

#MIDD #Pharmacometrics #Oncology

[ISoP @ISOP1]

🚨 New in the second issue of #QuantitativeMedicine!
A Population Pharmacokinetic and Receptor Occupancy Model of CD47-SIRPα–Targeting Fusion Protein Maplirpacept in Adult Patients with Hematologic Malignancies†

📖 Read the full article https://t.co/lpPjXDs0Ey

#ISoP

[ISoP @ISOP1]

🚀 New in Quantitative Medicine: How can we make population PK estimation faster without sacrificing robustness? Read "Performance of Parameter Estimation in Population Pharmacokinetics using Automatic Differentiation”

🔗 https://t.co/aY8cRUNmAb

#ISoP #PopPK #MIDD

[ISoP @ISOP1]

🌟 Meet Another Leader Empowering ISoP’s Next Generation 🌟

We’re excited to spotlight the volunteers serving on the Students, Trainees & Early career Professionals (STEP) Committee leadership.

👉 Learn about ISoP student membership https://t.co/Oj5CQ5G3kE

#ISoP

[ISoP @ISOP1]

🔬 Pharmacometrics Meets Statistics: Building Bridges for Modern Drug Development

🗓 July 9, 2026 |⏰ 12:00 PM ET
🎤 Alex Sverdlov, Senior Director, Novartis
🔗 https://t.co/MWEs65Ayrb

#ISoP #Pharmacometrics #Statistics #DrugDevelopment #MIDD #ClinicalResearch #Modeling

[ISoP @ISOP1]

AI/ML SIG Leaders

Peter Bloomingdale: Agentic Workflows Working Group Co-Lead
Ari Pritchard-Bell: Agentic Workflows Working Group Co-Lead
Ali Farnoud: Regulatory & Scientific Engagement Lead
Lindsay Clegg: Education Lead
Samuel Miles: Secretary

👉https://t.co/ougXVn0MAG

#ISoP

[ISoP @ISOP1]

��Model-Integrated Evidence: A Vision to Expand the Role of Modeling in Drug Development and Regulatory Decision-Making”

A forward-looking perspective on using modeling as core evidence to drive smarter development + regulatory decisions.

🔗https://t.co/lnMU5czx3g

#MIDD #ISoP

[ISoP @ISOP1]

🌟 Meet Another Leader Empowering ISoP’s Next Generation 🌟

We’re excited to spotlight the volunteers serving on the Students, Trainees & Early career Professionals (STEP) Committee leadership.

👉 Learn about ISoP student membership https://t.co/7t9wzg8hjt

#ISoP

[ISoP @ISOP1]

🛍️ New items added to the ISoP Store!

The ISoP Store offers a wide range of custom ISoP-branded apparel and accessories.

🛒 Start shopping now: https://t.co/ev1mBIpIj2

#ISoP #MemberBenefits #ISoPStore #Pharmacometrics #ProfessionalCommunity #ISoPGear